| Active Ingredient | Fenbendazole |
| Manufacturer | Weefsel Pharma |
| Packaging | 10 X 10 Tablets |
| Strength | 500 Mg |
| Delivery Time | 14-16 Days |
| SKU | Weefen 500 Mg |
| Pack | Price | Qty | Add |
|---|---|---|---|
| 100 Tablets | $100.00 | ||
| 300 Tablets | $230.00 | ||
| 500 Tablets | $380.00 | ||
| 1000 Tablets | $850.00 |
Weefen 500 mg is the highest-strength Fenbendazole tablet in the Weefen product range produced by Weefsel Pharma. Fenbendazole belongs to the benzimidazole class of anthelmintic compounds with a well-established record of use in veterinary medicine for treating and controlling a broad range of parasitic worm infections in animals.
The 500mg formulation provides the maximum per-tablet Fenbendazole dose within the Weefen range — making it a practical option where higher individual tablet strength is required as determined by a qualified professional, without needing multiple tablets to reach the required dose.
Weefen 500 mg Tablets are manufactured by Weefsel Pharma, a pharmaceutical manufacturer producing Fenbendazole formulations in certified pharmaceutical facilities. Each production batch is subjected to rigorous quality control testing to ensure consistent product purity, potency, and safety in every tablet supplied.
Fenbendazole demonstrates a significantly stronger binding affinity for parasitic beta-tubulin compared to mammalian beta-tubulin — which is the established basis of its selective antiparasitic activity in veterinary use.
For veterinary use:
For any use under healthcare professional supervision:
There is no established FDA-approved human dosage for Fenbendazole.
In veterinary practice, dosage is individually determined according to:
The Weefen 500 mg tablet — as the highest strength in the Weefen range — is particularly useful in situations where larger weight-based doses are required, as it reduces the number of tablets needed per administration compared to lower-strength formulations.
The complete Weefen range — 150mg, 222mg, 444mg, and 500mg — allows supervising professionals to select the most appropriate tablet strength for individual dosing requirements without the need for tablet splitting or combining multiple lower-strength tablets.
For any use under healthcare professional supervision, the supervising provider determines the appropriate strength, amount, frequency, and duration based on individual clinical circumstances.
Treatment duration with Weefen 500 mg depends entirely on the type of parasitic infection and the professional assessment of the supervising veterinarian or healthcare provider.
A 3-day consecutive daily course is widely referenced in veterinary Fenbendazole protocols for many common parasitic infections. Some conditions may require extended treatment periods or repeated cycles based on follow-up parasitological assessment and clinical response.
Complete the full prescribed course without stopping early even when visible symptoms appear to resolve before treatment ends. Periodic stool examinations or other follow-up assessments may be recommended to confirm successful parasite elimination. Do not discontinue or extend treatment without direct professional guidance.
If a dose is missed, administer it as soon as possible. If the next scheduled dose is approaching, skip the missed dose and continue the regular prescribed schedule. Never administer a double dose to compensate for a missed one. Seek guidance from the supervising veterinarian or healthcare professional if uncertain about how to proceed.
Most reported effects in veterinary use are mild and temporary.
Commonly noted in veterinary use:
In limited human cases reported under medical supervision:
Do not use Weefen 500 mg in the following situations without direct professional guidance:
Limited formal drug interaction data exists for Fenbendazole. Based on currently available information:
Always inform the supervising veterinarian or healthcare professional about every medicine, supplement, and product currently in use before starting Weefen 500 mg.
A: Weefen 500 mg is a Fenbendazole-based antiparasitic product used in veterinary practice for treating roundworm, hookworm, whipworm, certain tapeworm, and Giardia infections in animals including dogs, cats, horses, cattle, and livestock. Any use outside established veterinary applications must be under direct qualified professional supervision.
A: The 500mg tablet is the highest per-tablet dose in the Weefen range. For animals or situations requiring a higher weight-based dose, the 500mg tablet reduces the total number of tablets needed per administration compared to using multiple lower-strength tablets — as determined by a supervising professional.
A: Weefsel Pharma produces the Weefen range in four strengths — 150mg as the entry-level option, 222mg as an intermediate strength, 444mg as the most widely referenced formulation, and 500mg as the highest strength in the range. Strength selection must always be made by a qualified professional.
A: No. Fenbendazole does not hold FDA approval for any human medical indication. It is classified as a veterinary antiparasitic compound. Any consideration of human use must only be under the direct supervision of a qualified healthcare professional.
A: In veterinary practice, a 3-day consecutive daily course is widely referenced for many parasitic infections. Some conditions may require extended or repeated treatment cycles based on follow-up assessment. Duration is always determined by the supervising veterinarian or healthcare professional.
A: In veterinary use, Fenbendazole may be given with or without food depending on veterinary recommendations.
A: Administer the missed dose as soon as possible. If the next scheduled dose is approaching, skip the missed dose and continue the regular schedule. Never administer a double dose. Seek professional guidance if uncertain.
A: In veterinary use, mild digestive upset, temporary appetite loss, diarrhea, and transient lethargy have been noted in some animals. In supervised human contexts, nausea, stomach discomfort, dizziness, and elevated liver enzyme levels have been reported. Seek immediate professional attention for any severe or unexpected adverse reaction.
A: Store at room temperature below 25°C away from sunlight and moisture in the original 10 x 10 packaging. Keep out of reach of children and pets at all times and do not use past the printed expiry date on the packaging.
A: Weefen 500 mg Fenbendazole Tablets are manufactured by Weefsel Pharma in certified pharmaceutical manufacturing facilities under rigorous quality control standards ensuring consistent tablet potency and purity in every batch produced.
Medical Disclaimer: The information shown above is for educational purposes only. Please consult your doctor or a licensed healthcare professional before taking any medicine. Never start, stop, or change any treatment without professional medical advice.
Reviews
There are no reviews yet.